Oligonucleotide N3' --> P5' thio-phosphoramidate telomerase template antagonists as potential anticancer agents. 2003

Sergei Gryaznov, and Akira Asai, and Yuko Oshima, and Yoshihiro Yamamoto, and Krisztina Pongracz, and Ronald Pruzan, and Ellen Wunder, and Mieczyslaw Piatyszek, and Shihong Li, and Allison Chin, and Calvin Harley, and Shiro Akinaga, and Yoshinori Yamashita
Geron Corporation, Menlo Park, California 94025, USA. sgryaznov@geron.com

Human telomerase is a reverse transcriptase that is expressed in essentially all cancer cells, but not in the vast majority of normal somatic cells. Therefore, the specific inhibition of telomerase activity in tumors might have significant beneficial therapeutic effects. We have designed and evaluated oligonucleotide N3' --> P5' thio-phosphoramidates as telomerase template antagonists. In biochemical cell-free assays 11-13-mer thio-phosphoramidate oligonucleotides demonstrated sequence specific and dose dependent inhibition of telomerase with pico-molar IC50 values. Optimization of the oligonucleotide sequence and length resulted in the identification of a 13-mer-oligonucleotide thio-phosphoramidate GRN163 as a drug development candidate. In cell cultures GRN163 was able to inhibit telomerase activity in the absence of cationic lipid with approximately 1 microM IC50 values. Telomerase inhibition by GRN163 produced gradual telomere shortening, followed by cellular senescence and/or apoptosis of cancer derived cell lines.

UI MeSH Term Description Entries
D009841 Oligonucleotides Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed) Oligonucleotide
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D013698 Templates, Genetic Macromolecular molds for the synthesis of complementary macromolecules, as in DNA REPLICATION; GENETIC TRANSCRIPTION of DNA to RNA, and GENETIC TRANSLATION of RNA into POLYPEPTIDES. Genetic Template,Genetic Templates,Template, Genetic
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D019098 Telomerase An essential ribonucleoprotein reverse transcriptase that adds telomeric DNA to the ends of eukaryotic CHROMOSOMES. Telomerase Catalytic Subunit,Telomerase Reverse Transcriptase,Telomerase Reverse Transcriptase Catalytic Subunit,Catalytic Subunit, Telomerase,Reverse Transcriptase, Telomerase,Subunit, Telomerase Catalytic,Transcriptase, Telomerase Reverse

Related Publications

Sergei Gryaznov, and Akira Asai, and Yuko Oshima, and Yoshihiro Yamamoto, and Krisztina Pongracz, and Ronald Pruzan, and Ellen Wunder, and Mieczyslaw Piatyszek, and Shihong Li, and Allison Chin, and Calvin Harley, and Shiro Akinaga, and Yoshinori Yamashita
February 2007, Cancer research,
Sergei Gryaznov, and Akira Asai, and Yuko Oshima, and Yoshihiro Yamamoto, and Krisztina Pongracz, and Ronald Pruzan, and Ellen Wunder, and Mieczyslaw Piatyszek, and Shihong Li, and Allison Chin, and Calvin Harley, and Shiro Akinaga, and Yoshinori Yamashita
March 2010, Chemistry & biodiversity,
Sergei Gryaznov, and Akira Asai, and Yuko Oshima, and Yoshihiro Yamamoto, and Krisztina Pongracz, and Ronald Pruzan, and Ellen Wunder, and Mieczyslaw Piatyszek, and Shihong Li, and Allison Chin, and Calvin Harley, and Shiro Akinaga, and Yoshinori Yamashita
August 2005, Oncogene,
Sergei Gryaznov, and Akira Asai, and Yuko Oshima, and Yoshihiro Yamamoto, and Krisztina Pongracz, and Ronald Pruzan, and Ellen Wunder, and Mieczyslaw Piatyszek, and Shihong Li, and Allison Chin, and Calvin Harley, and Shiro Akinaga, and Yoshinori Yamashita
October 2003, Cancer research,
Sergei Gryaznov, and Akira Asai, and Yuko Oshima, and Yoshihiro Yamamoto, and Krisztina Pongracz, and Ronald Pruzan, and Ellen Wunder, and Mieczyslaw Piatyszek, and Shihong Li, and Allison Chin, and Calvin Harley, and Shiro Akinaga, and Yoshinori Yamashita
December 1999, Biochimica et biophysica acta,
Sergei Gryaznov, and Akira Asai, and Yuko Oshima, and Yoshihiro Yamamoto, and Krisztina Pongracz, and Ronald Pruzan, and Ellen Wunder, and Mieczyslaw Piatyszek, and Shihong Li, and Allison Chin, and Calvin Harley, and Shiro Akinaga, and Yoshinori Yamashita
March 2024, Cancer research,
Sergei Gryaznov, and Akira Asai, and Yuko Oshima, and Yoshihiro Yamamoto, and Krisztina Pongracz, and Ronald Pruzan, and Ellen Wunder, and Mieczyslaw Piatyszek, and Shihong Li, and Allison Chin, and Calvin Harley, and Shiro Akinaga, and Yoshinori Yamashita
January 2002, Oncogene,
Sergei Gryaznov, and Akira Asai, and Yuko Oshima, and Yoshihiro Yamamoto, and Krisztina Pongracz, and Ronald Pruzan, and Ellen Wunder, and Mieczyslaw Piatyszek, and Shihong Li, and Allison Chin, and Calvin Harley, and Shiro Akinaga, and Yoshinori Yamashita
April 1996, Nucleic acids research,
Sergei Gryaznov, and Akira Asai, and Yuko Oshima, and Yoshihiro Yamamoto, and Krisztina Pongracz, and Ronald Pruzan, and Ellen Wunder, and Mieczyslaw Piatyszek, and Shihong Li, and Allison Chin, and Calvin Harley, and Shiro Akinaga, and Yoshinori Yamashita
January 2005, Nucleosides, nucleotides & nucleic acids,
Sergei Gryaznov, and Akira Asai, and Yuko Oshima, and Yoshihiro Yamamoto, and Krisztina Pongracz, and Ronald Pruzan, and Ellen Wunder, and Mieczyslaw Piatyszek, and Shihong Li, and Allison Chin, and Calvin Harley, and Shiro Akinaga, and Yoshinori Yamashita
January 2002, Nucleic acids research,
Copied contents to your clipboard!